Independent industry coverage
FDA • MedTech • Biotechnology • Healthcare Business
Medical Device News and MedTech Industry News
Stay informed with the latest medical device news and developments shaping the global MedTech industry. Medical Device News Magazine delivers coverage of innovative medical technologies, FDA approvals and clearances, clinical trials, product launches, and emerging technologies transforming patient care.
Explore news and insights from medical device manufacturers, healthcare technology companies, researchers, and industry leaders. From advances in medical imaging and artificial intelligence to regulatory developments, funding, and acquisitions, our coverage helps healthcare professionals, industry executives, and investors stay informed about the evolving medical device landscape.
The study was led by Dr. Michael Freund of the Hebrew University of Jerusalem (HU) Faculty of Medicine and Shaare Zedek Medical Center in collaboration with Prof. David Hazzan of Raphael Hospital, Sheba Medical Center and Tel Aviv University
New collaborative program brings together an industry leading biologic graft, wound care specific revenue cycle management and the only clawback protection program in one coordinated solution
BIS to support customers through a phased transition, with commercial sales expected to continue through March 31, 2026
Under the terms of the agreement, SurGenTec® has secured exclusive rights to Allevion Medical’s Vantage™, a fully disposable, sterile system designed to simplify and enhance minimally invasive lumbar decompression procedures
Very soft, 100% TPU combines 65A performance with chemical resistance, thin-wall processability, and manufacturing versatility
Collaboration expands access to Lunit’s AI-powered pathology platform by combining it with Discovery Life Sciences’ global biospecimen and specialty laboratory capabilities, enabling standardized tissue insights for biomarker research and drug development
A redesigned patient experience drives engagement from prevention through survivorship, while chart-aware risk intelligence surfaces guideline-based recommendations in EHR workflows
104 IPF patients enrolled in US and South Korea as global Phase 2 trial progresses toward completion
Any connected device can be exploited. Recognizing that truth, we must try to ensure that when a vulnerability inevitably emerges, there’s a plan, and everyone involved knows what to do next
The future of robotic surgery won’t be defined solely by how advanced the robot becomes. It will also be defined by how well the technologies around it help clinicians deliver safer, more consistent and more patient-centered care
A practical framework for helping clinicians move from product to practice | By Steve Deverall, CEO and co-founder of InfuseMed
Why Growing Device Companies Should Stop Copying Big Pharma’s Technology Playbook
The company that invented VR visual testing, now trusted in 2,500+ clinics for more than 6 million eye exams, will add immersive, interactive IOL simulation—bringing testing, diagnostics and simulation onto one platform
Series D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate
The financing will support SedMed’s next phase of commercial growth and expand access to its non-electric toilet lift, which is designed to help older adults and individuals with mobility limitations sit and stand more safely and independently while reducing strain on caregivers
Combination pairs Labsphere’s light generation, control, and measurement platform with Photon Gear’s custom lens design, assembly, and interferometric test
BOLT-DVT, a recent prospective, multicenter Investigational Device Exemption (IDE) trial, demonstrated first-line use of computer assisted vacuum thrombectomy (CAVT) for DVT is safe and effective
Temporary knee spacer delivers antibiotics directly to an infected joint while providing load-bearing structural support during treatment
For the first time, U.S. CardioMEMS patients will be able to view pulmonary artery pressure (PAP) readings and receive personalized medication updates through the CardioGuide HF App. Rising PAP can signal worsening heart failure weeks before patients experience symptoms.
New capabilities help patients take a more active role in their care and stay connected to their care teams between doctor visits
The new clearances expand its reach to additional brain targets and conditions, including obsessive-compulsive disorder (OCD), MDD comorbid anxiety, and extend care to adolescent patients
The BCL Trial is an international, prospective, multicenter, randomized controlled trial conducted at 23 sites by 44 surgeons in the U.S., Canada, U.K., and Austria comparing the effectiveness and safety of the BCL System versus conventional WL in 418 patients with non-palpable, MRI-visualized invasive breast cancer or DCIS
AI-powered analysis of Phase 3 CHARM trial suggests that Brainomix non-contrast CT (NCCT) technology may help identify severe stroke patients more likely to benefit from CIRARA, supporting more precise patient selection and the design of future stroke trials.
Peer-reviewed Data Published in EuroIntervention Also Demonstrated Vertex System Achieved Rapid Afterload Relief – or Reduction in Heart Strain – and Symptom Improvement
The bioelectronic medicine trial will study how non-invasive stimulation might treat pain and fatigue in patients with lupus
Dave brings more than 30 years of experience in precision motion, automation and advanced technology markets.
Jennings brings more than 20 years of healthcare industry leadership experience and a proven track record of driving growth, innovation and transformation across global healthcare organizations
Riccardo Fava brings more than 20 years of experience across the medtech and financial sectors.
Former Chief Scientific Officer of Internal Medicine at Pfizer: Leading vascular biologists from Yale, Harvard, Uppsala and the University of Eastern Finland join Sessa to advise on the development of ISM-001, Isomab’s first-in-class anti-VEGF-A165b antibody for chronic angina
Exclusive Report by MarketsandMarkets™
